Clinical trial Recruiting at 1 site Interventional Ages 40 and up

Remote arm‑cuff conditioning plus stent placement for symptomatic carotid narrowing

Official title: Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis (RICSICAS): A Prospective, Randomized Controlled, Blind Endpoint, Single-Center Study

Run by General Hospital of Shenyang Military Region · NCT07412249 · Data updated 2026-11-12

This study tests whether regular remote limb ischemic conditioning after carotid artery stenting can lower major vascular events and improve outcomes for adults with symptomatic carotid artery narrowing.

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment300 (estimated)
SponsorGeneral Hospital of Shenyang Military Region
Academic / other
Locations1 site (Shenyang)
StatusRecruiting
StartedMarch 4, 2026
Main results expectedNovember 30, 2027
Study endsNovember 30, 2027
Registry record updatedApril 3, 2026
Trial IDNCT07412249 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40 or older with symptomatic moderate-to-severe internal carotid artery stenosis, ipsilateral ischemic symptoms within the past 180 days, an Essen score ≥ 3, a modified Rankin Scale of 0–1, and a planned carotid artery stent are ideal candidates.

Probably not a fit

Patients with contraindications to RIC (for example significant peripheral or upper-limb vascular disease, severe soft tissue injury or fracture of the arm), uncontrolled severe hypertension, significant subclavian stenosis/steal, severe hematologic or coagulation disorders, very limited life expectancy, or who do not have recent symptomatic carotid stenosis may not receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls adults with recent ipsilateral cerebral ischemic symptoms and moderate-to-severe internal carotid artery stenosis who are scheduled for carotid artery stenting, and applies chronic remote ischemic conditioning after the procedure while monitoring patients over the long term. Remote ischemic conditioning (RIC) is a non-invasive approach that uses brief, repeated limb ischemia cycles to trigger protective mechanisms in the brain. The trial tracks incidence of major vascular events and clinical functional outcomes and records safety data related to prolonged RIC use. Results will determine whether chronic RIC adds long-term benefit to patients who receive carotid stents.

Why it matters

Potential benefit: If successful, this approach could reduce major vascular events and improve recovery and long-term function after carotid artery stenting.

How similar studies have gone: Smaller and short-term studies of remote ischemic conditioning in stroke and in patients undergoing carotid procedures have suggested potential benefit, but long-term efficacy and safety after carotid stenting remain unproven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 40 years old;
* Patients with symptomatic moderate to severe stenosis of the internal carotid artery;
* History of ipsilateral cerebral ischemic symptoms within the past 180 days;
* Planned for carotid artery stent;
* Essen Score ≥ 3;
* Modified Rankin Scale score of 0 or 1;
* Signed informed consent.

Exclusion Criteria:

* Uncontrolled severe hypertension (systolic blood pressure \> 180 mmHg or diastolic blood pressure \> 110 mmHg despite medication)
* Subclavian artery stenosis ≥ 50% or presence of subclavian steal syndrome
* Severe hematological disorders or significant coagulation abnormalities
* Contraindications to remote ischemic conditioning, such as severe soft tissue injury, fracture, or vascular injury in the upper limbs, or peripheral vascular disease in the distal upper limbs
* Severe comorbid conditions with a life expectancy of less than 1 year
* Participation in another clinical trial within the past 3 months or ongoing participation
* Any other circumstances deemed by the investigator as unsuitable for participation in this clinical study.

Where it's running

  • Department of Neurology, General Hospital of Northern Theater Command
    Shenyang, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.